or
Bookmark and Share
Substituted thieno[3,2-d]pyrimidines as CRF receptor antagonists
   
Document Number
US Patent 7557111
Issued Date
July 7, 2009
Link
Map
Abstract
An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alpecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc.A thienopyrimidine or thienopyridine derivative substituted with a cyclic amino group represented by the following formula [I]: ##STR00001## has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
7
Comments:
no comments yet
Published
July 7, 2009
Application Number
10/584,951
Filed
January 6, 2005
US Classification
514/260.1   544/278
Int'l Classification
C07D   495/04   (20060101)   A61K   31/519   (20060101)  
Assistant Examiner
Attorney/Law Firm
Priority Data
Jan 06, 2004 [JP] 2004-001310
USPTO Field of Search
544/114   514/301  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us